Marshall Wace North America’s Idexx Laboratories IDXX Stock Holding History

Marshall Wace North America’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$902K	Sell	1,451 -137,676	-99%	-$92.5M	﹤0.01%	959
2021 Q2	$87.9M	Sell	139,127 -116,822	-46%	-$64.5M	0.37%	57
2021 Q1	$125M	Buy	+255,949	New	+$128M	0.52%	34
2020 Q1	–	Sell	-212,005	Closed	-$55.4M	–	1400
2019 Q4	$55.4M	Sell	212,005 -154,182	-42%	-$40.6M	0.27%	108
2019 Q3	$99.6M	Sell	366,187 -332,040	-48%	-$92.4M	0.57%	47
2019 Q2	$192M	Buy	698,227 +294,186	+73%	+$72.5M	1.19%	17
2019 Q1	$90.3M	Buy	404,041 +369,991	+1,087%	+$76.4M	0.64%	41
2018 Q4	$6.33M	Sell	34,050 -20,962	-38%	-$4.3M	0.06%	216
2018 Q3	$13.7M	Buy	55,012 +34,404	+167%	+$8.35M	0.09%	178
2018 Q2	$4.49M	Sell	20,608 -436,606	-95%	-$90M	0.03%	540
2018 Q1	$87.5M	Sell	457,214 -226,080	-33%	-$41.7M	0.44%	54
2017 Q4	$107M	Buy	683,294 +437,667	+178%	+$68.9M	0.59%	31
2017 Q3	$38.1M	Buy	+245,627	New	+$38.8M	0.24%	103
2013 Q4	–	Sell	-5,800	Closed	-$289K	–	763
2013 Q3	$289K	Buy	+5,800	New	+$279K	0.01%	520

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marshall Wace North America's IDXX Position: Q3 2021 in Review

Marshall Wace North America reduced its Idexx Laboratories (IDXX) stake by 99% in Q3 2021, selling an estimated $92.5M and leaving 1,451 shares worth $902K. The position accounts for ﹤0.01% of the portfolio, ranked #959.

Marshall Wace North America first reported a position in IDXX in Q3 2013 and has held it in 14 quarters since. The position peaked at $192M in Q2 2019. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

Marshall Wace North America held 1,451 shares of Idexx Laboratories worth $902K as of Q3 2021.
Marshall Wace North America sold 137,676 Idexx Laboratories shares in Q3 2021, an estimated $92.5M.
Idexx Laboratories made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #959 holding.
Marshall Wace North America first reported a position in Idexx Laboratories in Q3 2013 and has held it in 14 quarters since.
Marshall Wace North America's Idexx Laboratories position peaked at $192M in Q2 2019.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.